Brands: Risperdal Consta · Rykindo Extended-Release Microspheres
Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | generic | 4 | SUPPLYING |
| Janssen Pharmaceuticals, Inc | unknown | 4 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | generic | 3 | SUPPLYING |
| Shandong Luye Pharmaceutical Co., Ltd. | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Non-Sterility: Janssen is recalling one lot of Risperdal CONSTA (risperiDONE) due to a sterility failure in a stability sample — Recalling firm: Janssen Pharmaceuticals, Inc. — Nationwide
